This trial is comparing two types of radiation therapy to treat early-stage breast cancer.
1 Primary · 8 Secondary · Reporting Duration: Time from randomization to death from any cause, assessed up to 10 years
Active Control
Experimental Treatment
1636 Total Participants · 4 Treatment Groups
Primary Treatment: regional nodal XRT · No Placebo Group · N/A
Age 18+ · Female Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: